QualityStocks Stock Newsletters Archives - Page 689 of 1818

TuesdaySep 15, 2009 8:25 am

Protalix Biotherapeutics, Inc. (PLX) Completes Phase III Trial for Gaucher Disease Treatment

Protalix Biotherapeutics, Inc. continues to make headlines with its innovative compound, a recombinant form of glucocerebrosidase (prGCD). Last week, the company released that its compound had received the FDA’s Orphan Drug Donation. Yesterday, the company announced that they have completed the Phase III trial for prGCD. The compound is designed to treat Gaucher disease, a rare and serious lysosomal storage disorder in humans with debilitating symptoms. Protalix plans to release top-line results from this study in October 2009, but has shed light on a few details; the trial enrolled 31 patients across Europe, North America, South America, Israel and South…

MondaySep 14, 2009 2:45 pm

ALR Technologies, Inc. (ALRT) Up 425% Following QualityStocks Newsletter Mention

ALR Technologies, Inc.’s stock is currently trading at $0.21, up 425%, on massive volume of 3.3+ million traded shares. Earlier this month, QualityStocks highlighted the company in its daily newsletter when the stock was trading for only $0.04 and largely ignored by the investment community. To sign up for the newsletter, visit www.signup.qualitystocks.net. Today, ALR Technologies announced that the US Patent and Trademark Office has approved its patent application regarding patient compliance and remote monitoring of patient's use of nebulizer compressors. This approval protects the company’s Health-E-Connect health management communications system and, more importantly, grants ALRT the exclusive ability to…

MondaySep 14, 2009 2:33 pm

President Obama Issues Stern Warning to Wall Street and its “Reckless Behavior”

We face the fourth quarter with hopes of reform and rebuilding paired with an obvious and earned distrust for the government, Wall Street and the mortgage and banking systems. Between bankruptcies, bailouts and layoffs, some feel that we hit the bottom of the worst economic storm since the Great Depression, and that the next step is to make sure we don’t let history repeat itself. President Barack Obama threw stern words at Wall Street this morning, reminding it of the irresponsible behaviors that drove the U.S. into recession and warning not to fall back into reckless habits. On the first…

MondaySep 14, 2009 1:49 pm

NanoViricides, Inc. (NNVC.OB) Closing In On Magic Bullet

Anil Diwan, Ph.D., president of NanoViricides, Inc., a development stage company creating special purpose nanomaterials for viral therapy, revealed the remarkable potential of this new class of drugs for the treatment of viral disease in a presentation given at the 8th annual NanoBusiness Conference in Chicago recently. NanoViricides has created a class of drug candidates, under the Nanoviricide™ name, that comes as close as anything to the sought after “magic bullet”, able to zero in on specific virus particles and dismantle them. The company is already developing drugs against a number of viral diseases, including H1N1 swine flu, H5N1 bird…

MondaySep 14, 2009 12:51 pm

AMG Oil Ltd. (AMGOF.OB) Enters Letter of Intent with Brownstone Ventures

AMG Oil Ltd., through its wholly-owned subsidiary Adira Energy Corp., explores for oil and gas in Israel within areas located on-shore in the Hula Valley and also 10 kilometers offshore between Netanya and Ashdod. The company currently holds two oil exploration licenses, the Eitan license and the Gabriella license, which together cover an aggregate total of about 129,000 acres. The company has announced that it has entered into a letter of intent with Brownstone Ventures, a Canadian-based energy investment company that holds interests in numerous international oil and gas properties. Pursuant to this agreement, Brownstone will have the right to…

MondaySep 14, 2009 12:47 pm

Vivakor, Inc. (VIVK.OB) Announces Completion of Independent Testing of Its VivaBlend Nutraceutical

Biomedical company Vivakor Inc. announced today the results of independent, third-party testing of its VivaBlend nutraceutical product. This product is a powerful extract developed by Vivakor scientists and is derived from over 18 highly bioactive fruits, vegetables and legumes. Through a proprietary formulation and extraction process, the company's scientists created an optimum blend of super-oxidants, flavonoids and powerful plant phenolics. The results from third-party testing show that VivaBlend contains a much higher level of antioxidants, phytochemicals and lipophilic antioxidants, from a wider array of plant sources, than its competitors. Lipophilic antioxidants penetrate the lipoprotein cell membrane more easily than other…

MondaySep 14, 2009 10:17 am

Compton Petroleum Corp. (CMZ) Raises $150 Million

Compton Petroleum Corporation released the terms of its recently announced $150 million equity offering. The company will issue 120,000 units at $1.25 each. Each unit comprises one share of stock and one warrant. Each warrant conveys the right to purchase one share of Compton Petroleum common stock at a price of $1.55 per share. The warrants expire 24 months after issuance. Compton Petroleum said the funds would be used to pay down debt. Tim Granger, the CEO of Compton Petroleum stated, “This transaction is an important first step in our restructuring process, contributing to our future ability to unlock the…

MondaySep 14, 2009 10:15 am

GENova Biotherapeutics, Inc. (GVBP.OB) to Acquire Drug Patents Worth Over $1 Billion in Royalties

With great excitement, GENova Biotherapeutics, Inc., a biotechnology company that develops proteins to disrupt the advance of life-threatening diseases, recently announced that it is in the process of acquiring three promising new drug target patents that could generate over a billion dollar in royalty fees in the mid to long term. Aaron Whiteman, CEO for GENova commented, "Following a rigorous evaluation phase, we have selected three potential blockbuster drug target patents for acquisition, and we look forward to integrating them into our IP portfolio." GENova will announce details of these new biological products in the coming weeks. The three new…

MondaySep 14, 2009 10:06 am

Day4 Energy Inc. (DFE.TO) Introduces the Next Generation of Solar Electric Modules

There is a hidden gem on the Toronto Stock Exchange and its name is Day4 Energy. Day4 has been gaining national recognition as a leading technology developer and manufacturer of high performance solar electric molecules. Today, the company took a major step forward when they announced the expansion of its product offering to include the Day4 60MC-I featuring the breakthrough Guardian Technology. Guardian Technology is unique in that it dramatically improves the performance of the photovoltaic (PV) modules when exposed to partial shading, snow, debris and other external factors that under normal circumstances cause a substantial reduction in power yield.…

MondaySep 14, 2009 8:39 am

China Natural Gas, Inc. (CHNG) Raises Equity Capital

China Natural Gas, Inc. recently completed its secondary public offering of common stock, raising $47.5 million in net proceeds for the company. China Natural Gas, Inc. sold 5.725 million shares at a price of $8.75 per share. Qinan Ji, the CEO of China Natural Gas, commented, "We are very pleased to announce the closing of this public offering. We believe this transaction will ensure the future growth of our LNG business and expansion of our existing CNG business, as well as further strengthen our balance sheet and enhance our working capital.” China Natural Gas, Inc. owns and operates a 120…

Site Search

Company Search

Category: QualityStocks Stock Newsletters